Virios therapeutics to present at the thinkequity conference on thursday, october 19, 2023

Atlanta, oct. 12, 2023 (globe newswire) -- virios therapeutics, inc. (nasdaq: viri) (the “company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases such as fibromyalgia and long-covid, announced today that greg duncan, chairman and chief executive officer, will present at the annual thinkequity conference on thursday, october 19, 2023 at 11:00 am et in new york, ny.
VIRI Ratings Summary
VIRI Quant Ranking